Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study

被引:5
作者
Vermes, Gabor [1 ]
Laszlo, Daniel [2 ]
Czeizel, Andrew E. [3 ]
Acs, Nandor [4 ]
机构
[1] Mil Hosp State Hlth Ctr, Dept Obstet & Gynecol, Budapest, Hungary
[2] St Stephens Hosp, Dept Obstet & Gynecol, Budapest, Hungary
[3] Fdn Community Control Hereditary Dis, Budapest, Hungary
[4] Semmelweis Univ, Sch Med, Dept Obstet & Gynecol 2, Ulloi Ut 78-a, H-1082 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
hyperthyroidism; infantile hypertrophc pyloric stenosis; nalidixic acid; population based case-control study; pregnancy; EXPOSURE IN-UTERO; CONGENITAL-ABNORMALITIES; MACROLIDE ANTIBIOTICS; PRENATAL PRESCRIPTION; CHOANAL ATRESIA; URINARY-TRACT; METHIMAZOLE; PREGNANCY; HYPERTHYROIDISM; RISK;
D O I
10.1111/cga.12134
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In most patients affected by isolated infantile hypertrophic pyloric stenosis (IHPS) the etiology is largely unknown. Thus, the aim of this study was to estimate possible maternal risk factors in the origin of IHPS. The study samples included 241 cases with IHPS, 357 matched controls and 38151 population controls without any defect in the population-based large dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Exposures that had been medically recorded in prenatal maternity logbooks during the critical period of IHPS were evaluated separately. The findings of this case-control study suggested that - beyond the well-known robust male excess (85.5%) - maternal hyperthyroidism (OR with 95% CI: 4.17, 1.53-11.38) and oral nalidixic acid treatment (OR with 95% CI: 6.53, 3.03-14.06) associated with a higher risk for IHPS in their children. In conclusion, our findings suggest that cases with IHPS had mothers with a higher proportion of hyperthyroidism and nalidixic acid treatment during pregnancy.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 74 条
  • [1] Periconceptional Folic Acid and Multivitamin Supplementation for the Prevention of Neural Tube Defects and Other Congenital Abnormalities
    Andrew E. Czeizel
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (04) : 260 - 268
  • [2] Andriole V., 1988, QUINOLONES
  • [3] Aspelund Gudrun, 2007, Semin Pediatr Surg, V16, P27
  • [4] DISEASES OF URINARY SYSTEM - URINARY-TRACT INFECTIONS
    ASSCHER, AW
    [J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6072) : 1332 - 1335
  • [5] Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects drug exposure surveillance study
    Bakker, Marian K.
    De Walle, Hermien E. K.
    Wilffert, Bob
    de Jong-Van Den Berg, Lolkje T. W.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (08) : 808 - 813
  • [6] Banhidy F, 2010, J MATERN-FETAL NEO M, V23, P107
  • [7] CARTER C O, 1969, Journal of Medical Genetics, V6, P233, DOI 10.1136/jmg.6.3.233
  • [8] INHERITANCE OF CONGENITAL PYLORIC STENOSIS
    CARTER, CO
    [J]. BRITISH MEDICAL BULLETIN, 1961, 17 (03) : 251 - &
  • [9] CARTER CO, 1954, LANCET, V1, P746
  • [10] Subclinical hyperthyroidism and pregnancy outcomes
    Casey, Brian M.
    Dashe, Jodi S.
    Wells, C. Edward
    McIntire, Donald D.
    Leveno, Kenneth J.
    Cunningham, F. Gary
    [J]. OBSTETRICS AND GYNECOLOGY, 2006, 107 (02) : 337 - 341